
Maria L Delioukina MD
Breast Cancer, Gynecologic Cancer, Hematologic Oncology
Physician
Join to view full profile
8700 Beverly BlvdWest Hollywood, CA 90048
Phone+1 310-423-1160
Fax+1 310-423-4646
Dr. Delioukina is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
Hennepin HealthcareResidency, Internal Medicine, 1995 - 1998
St Petersburg Medical State AcademyClass of 1987
Certifications & Licensure
CA State Medical License 1998 - 2027
Publications & Presentations
PubMed
- 12 citationsSwitching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots
Journal of Oncology Pharmacy Practice. 2023-07-01 - 8 citationsDaratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.Philippe Moreau, Ajai Chari, Albert Oriol, Joaquin Martinez-Lopez, Mathias Haenel
Blood Cancer Journal. 2023-03-07 - 43 citationsFinal analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma.Saad Z Usmani, Hareth Nahi, Wojciech Legiec, Sebastian Grosicki, Vladimir Vorobyev
Haematologica. 2022-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: